Comparison of Treatment Retention Between Risperidone Long-Acting Injection and First-Generation Long-Acting Injections in Patients With Schizophrenia for 5 Years

J Clin Psychopharmacol. 2016 Aug;36(4):405-6. doi: 10.1097/JCP.0000000000000533.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino, Yuichi Inoue, Atsuhiko Takaya

Affiliation

¹ Department of Psychiatry Suzuki Clinic Tokyo, Japan suzuhiromarket@yahoo.co.jp Department of Psychiatry Fukui Kinen Hospital Kanagawa, Japan Department of Psychiatry Shakomae Kokorono Clinic Tokyo, Japan Department of Psychiatry Fukui Kinen Hospital Kanagawa, Japan.

PMID: 27300251
DOI: 10.1097/JCP.0000000000000533

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Antipsychotic Agents / administration & dosage
Antipsychotic Agents / pharmacology*
Delayed-Action Preparations
Humans
Injections
Medication Adherence*
Risperidone / administration & dosage
Risperidone / pharmacology*
Schizophrenia / drug therapy*
Time Factors

Substances

Antipsychotic Agents
Delayed-Action Preparations
Risperidone